Immunotherapy for melanoma has revolutionised the treatment options for what can be a devastating disease – you’ve seen that we’ve talked time and time again about the newer agents that can be used. But what exactly is their role?
Now, the Society for Immunotherapy of Cancer has released a consensus statement published in Nature Reviews Clinical Oncology that talks about choosing the right patient, managing toxicity, and assessing end points.
Check out this great review here.
source | Nature Reviews Clinical Oncology
image | Wikimedia Commons